{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:54:00Z","timestamp":1790927640755,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.jinf.2011.05.015","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T00:07:16Z","timestamp":1307923636000},"page":"114-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region"],"prefix":"10.1016","volume":"63","author":[{"given":"Po-Ren","family":"Hsueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl J.","family":"Hoban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Carmeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shey-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Desikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Alejandria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Quang","family":"Binh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2011.05.015_bib1","article-title":"Guidelines for urological infections","author":"Grabe","year":"2009","journal-title":"Eur Assoc Urol"},{"key":"10.1016\/j.jinf.2011.05.015_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2010.11.2217","article-title":"Management of complicated urinary tract infections in the era of antimicrobial resistance","volume":"122","author":"Bader","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jinf.2011.05.015_bib3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/592250","article-title":"Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- andfluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis","volume":"47","author":"Talan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib4","article-title":"High rates of quinolone resistance among urinary tract infections in the ED","author":"Khawcharoenporn","year":"2010","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jinf.2011.05.015_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2011.05.015_bib6","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijantimicag.2007.07.033","article-title":"European and Asian guidelines on management and prevention of catheter-associated urinary tract infections","volume":"31","author":"Tenke","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2011.05.015_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib8","unstructured":"Badal R, Bouchillon S, Hawser S, Hackel M, Hsueh PR. Antimicrobial susceptibility of urinary tract Infection pathogens in Asia- SMART 2009. In. 12th Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2-5, 2010, Singapore. Abstract no. P026."},{"key":"10.1016\/j.jinf.2011.05.015_bib9","first-page":"185","article-title":"Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection","volume":"37","author":"Lau","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jinf.2011.05.015_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1442-200X.2008.02738.x","article-title":"Changing trend in antimicrobial resistance of pediatric uropathogens in Taiwan","volume":"50","author":"Tseng","year":"2008","journal-title":"Pediat Int"},{"key":"10.1016\/j.jinf.2011.05.015_bib11","first-page":"225","article-title":"Urinary tract infections in children","volume":"30","author":"Chiu","year":"1989","journal-title":"Acta Paedtr Sin"},{"key":"10.1016\/j.jinf.2011.05.015_bib12","first-page":"328","article-title":"Childhood urinary tract infection: a clinical analysis of 597 cases","volume":"45","author":"Wu","year":"2004","journal-title":"Acta Paediatr Taiwan"},{"key":"10.1016\/j.jinf.2011.05.015_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijantimicag.2008.01.010","article-title":"Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study","volume":"31","author":"Kuo","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2011.05.015_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1620\/tjem.214.311","article-title":"Species and antimicrobial resistance of uropathogens isolated from patients with urinary catheter","volume":"214","author":"Ko","year":"2008","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jinf.2011.05.015_bib15","first-page":"120","article-title":"Complicated urinary tract infection in a tertiary care center in South India","volume":"2","author":"Mahesh","year":"2010","journal-title":"Al Ameen J Med Sci"},{"key":"10.1016\/j.jinf.2011.05.015_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3855\/jidc.196","article-title":"Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study","volume":"2","author":"Kothari","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jinf.2011.05.015_bib17","first-page":"11","article-title":"Surveillance of pathogens and resistance patterns in urinary tract infections","volume":"28","author":"Dytan","year":"1999","journal-title":"Phil J Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib18","volume":"vol 2, No 1","year":"2004"},{"key":"10.1016\/j.jinf.2011.05.015_bib19","first-page":"29","article-title":"Clinical profile and susceptibility pattern of urinary tract infection in post kidney transplant patients at Cardinal Santos Medical Center","volume":"35","author":"Bomasang","year":"2006","journal-title":"Phil J Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1201-9712(97)90042-4","article-title":"Infections in renal allograft recipients. A review of the Philippine experience","volume":"1","author":"Mendoza","year":"1997","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib21","first-page":"65","article-title":"Urinary tract infection in patients with indwelling catheter","volume":"22","author":"Alavaren","year":"1993","journal-title":"Phil J Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib22","first-page":"133","article-title":"Catheter-related urinary tract infections: incidence, risk factors and microbiologic profile","volume":"28","author":"Billote-Domingo","year":"1999","journal-title":"Phil J Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib23","first-page":"286","article-title":"Evaluation of antibiotic resistance of gram-negative pathogens causing hospital-acquired infections","volume":"13-1","year":"2009","journal-title":"Tap Chi Y Hoc Thanh Pho Ho Chi Minh"},{"key":"10.1016\/j.jinf.2011.05.015_bib24","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1378\/chest.119.2_suppl.397S","article-title":"Resistance patterns among nosocomial pathogens: trends over the past few years","volume":"119","author":"Jones","year":"2001","journal-title":"Chest"},{"issue":"53","key":"10.1016\/j.jinf.2011.05.015_bib25","first-page":"3280","article-title":"Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program","volume":"2009","author":"Hawser","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2011.05.015_bib26","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/AAC.00123-06","article-title":"Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American urinary tract infection collaborative alliance-quinolone resistance study","volume":"50","author":"Karlowsky","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 4","key":"10.1016\/j.jinf.2011.05.015_bib27","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"Collateral damage from antibiotic therapy","volume":"38","author":"Patterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib29","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1128\/AAC.00597-06","article-title":"Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital","volume":"50","author":"Poirel","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2011.05.015_bib30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/AAC.50.2.498-504.2006","article-title":"Bloodstream infections caused by extended-spectrum-\u00df-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome","volume":"50","author":"Tumbarello","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2011.05.015_bib31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dki348","article-title":"Comparative in\u00a0vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients","volume":"56","author":"Edmiston","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2011.05.015_bib32","first-page":"271","article-title":"Guidelines for antimicrobial therapy of urinary tract infections in Taiwan","volume":"33","year":"2000","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jinf.2011.05.015_bib33","first-page":"532","article-title":"Physicians\u2019 adherence to guidelines for empirical treatment of urinary tract infection in Taiwan","volume":"40","author":"Jan","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jinf.2011.05.015_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijantimicag.2010.02.004","article-title":"Microbiological outcome of complicated urinary tract infections treated with levofloxacin: a pharmacokinetic\/pharmacodynamic analysis","volume":"35","author":"Deguchi","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2011.05.015_bib35","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1128\/AAC.00837-08","article-title":"Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis","volume":"53","author":"Naber","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2011.05.015_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2007.09.002","article-title":"A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400\/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis","volume":"71","author":"Peterson","year":"2008","journal-title":"Urology"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2011.05.015_bib37","first-page":"67","article-title":"Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy","volume":"53","author":"Wells","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2011.05.015_bib38","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/AAC.46.9.2895-2900.2002","article-title":"Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study","volume":"46","author":"Tomera","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2011.05.015_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.7196\/SAMJ.4109","article-title":"Guideline: appropriate use of tigecycline","volume":"100","author":"Brink","year":"2010","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jinf.2011.05.015_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1128\/JCM.01340-07","article-title":"Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-beta-lactamase-producing Escherichia coli","volume":"46","author":"Krueger","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.05.015_bib41","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/jac\/dkq224","article-title":"Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"65","author":"Geerlings","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2011.05.015_bib42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/14656560902811811","article-title":"Therapeutic options for infections due to vancomycin-resistant enterococci","volume":"10","author":"Wang","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jinf.2011.05.015_bib43","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute pyelonephritis in women: a 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.05.015_bib44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1684-1182(10)60041-2","article-title":"Guidelines for the use of antifungal agents in patients with invasive fungal infections in Taiwan-revised 2009","volume":"43","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jinf.2011.05.015_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/CMR.18.2.417-422.2005","article-title":"Diagnosis and management of pediatric urinary tract infections","volume":"18","author":"Zorc","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jinf.2011.05.015_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijantimicag.2008.08.005","article-title":"Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection","volume":"33","author":"Arguedas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2011.05.015_bib47","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/INF.0b013e3181e82608","article-title":"Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescents","volume":"29","author":"Abdel-Rahman","year":"2010","journal-title":"Pediatr Infect Dis J"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311003793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311003793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:15:07Z","timestamp":1759007707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445311003793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0163445311003793"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2011.05.015","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2011.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}